Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06293040 · ClinicalTrials.gov registry record · Phase 1
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
A Phase 1 study of Alcohol Intoxication and Cannabis Intoxication, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06293040 is a Phase 1 study of Alcohol Intoxication and Cannabis Intoxication that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 90 participants, below the 342-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06293040, a Phase 1 study of Alcohol Intoxication and Cannabis Intoxication, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This human laboratory study will use cognitive, behavioral, and subjective measures to characterize impairment associated with co-use of alcohol and vaporized cannabis. Participants (n=32) will complete 7 double-blind, double-dummy outpatient sessions in randomized order. In each session, participants will self-administer placebo (0 mg THC) or active vaporized cannabis (5 or 25 mg THC, via a handheld vaporizer called the Mighty Medic) and a placebo drink (BAC 0.0%) or alcohol drink calculated to produce a breath alcohol concentration (BAC) of 0.05%. Participants will also complete a positive control session in which the participant administers placebo cannabis and alcohol at a target BAC of 0.08% (the legal threshold for driving impairment in most U.S. states).
Conditions Studied
Interventions
- DRUG Alcohol
- DRUG Cannabis
- DRUG Placebo Cannabis
- DRUG Placebo Alcohol
Study Locations (1)
Maryland
- Johns Hopkins Behavioral Pharmacology Research Unit - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-09-26 |
| Est. Completion | 2027-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06293040
The ClinicalTrials.gov registry entry for NCT06293040 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 342-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (74% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Intoxication appearing as the primary indexed condition, and to 4 interventions - of which Alcohol is the first listed.
NCT06293040 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06293040 about?
NCT06293040 is a clinical study titled "Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment". This human laboratory study will use cognitive, behavioral, and subjective measures to characterize impairment associated with co-use of alcohol and vaporized cannabis. Participants (n=32) will complete 7 double-blind, double-dummy outpatient sessions in randomized order. In each session, participan...
What is the current status of trial NCT06293040?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2024-09-26. Estimated completion is 2027-12.
What conditions does trial NCT06293040 study?
This clinical trial studies the following conditions: Alcohol Intoxication, Cannabis Intoxication.
What interventions are being tested in trial NCT06293040?
The interventions under investigation include: Alcohol (DRUG), Cannabis (DRUG), Placebo Cannabis (DRUG), Placebo Alcohol (DRUG).
Who is sponsoring clinical trial NCT06293040?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06293040 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Intoxication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
COMPLETED · Phase 1
-
Acute and Residual Effects of Caffeinated Beer
COMPLETED · Phase 1
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
-
Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study
RECRUITING
-
Alcohol and Sexual Communication Among Couples in the Laboratory
RECRUITING · NA
-
Effect of Nutritional Ketosis on Alcohol Metabolism
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.